𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pentostatin in the treatment of hairy-cell leukemia

✍ Scribed by Michael R Grever; Charles A Doan; Eric H Kraut

Book ID
119614361
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
85 KB
Volume
16
Category
Article
ISSN
1521-6926

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of rituximab in combination wit
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
✍ Monica Else; Nnenna Osuji; Francesco Forconi; Claire Dearden; Ilaria Del Giudice πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

## Abstract ## BACKGROUND. The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall responses in greater than 85% of patients and a median progression‐free survival of up to 15 years. They continue to be effective at second‐ and even

Long term outcome of patients with hairy
Long term outcome of patients with hairy cell leukemia treated with pentostatin
✍ Patricia Ribeiro; Fadhela Bouaffia; Pierre-Yves Peaud; Michel Blanc; Bruno Salle πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

## BACKGROUND. With the introduction of new drugs such as interferon-␣ (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, pentostatin has been found to produce higher complete remission rates than IFN. The current study was undertaken to investigat